Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	76.96	-100.91	-438.02
Graham Fair Price	-59.20	0.40	0.98
PEG	5584.30	-0.34	< 0.005
Price/Book	-68.95	7.06	22.74
Price/Cash Flow	-184.49	-118.27	-41.57
Prices/Earnings	-172.62	-29.67	-10.88
Price/Sales	50.78	121.45	80.55
Price/FCF	-184.49	-118.27	-41.57
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-20.95	0.11	0.13
Operating Margin	31.97	-1.02	-1.51
ROA	88.64	-0.03	-0.23
ROE	-0.52	-0.06	88.61
ROIC	-0.45	-0.05	88.31
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.09	< 0.005	-1265.50
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-11.34	0.87	-92.35
EPS QOQ	-17.99	0.86	-95.20
FCF QOQ	-12.02	0.90	-92.54
Revenue QOQ	0.60	-0.81	34.51
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	280.33	1439.62	413.55
Days Sales Outstanding (DSO)	592.53	2986.20	403.98
Inventory Turnover	0.32	0.06	-80.53
Debt/Capitalization	0.09	0.08	-3.40
Quick Ratio	1.18	1.11	-6.29
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.29	0.35	20.88
Cash	0.23	0.24	6.65
Capex	< 0.005	< 0.005	98.99
Free Cash Flow	-0.16	-0.02	86.80
Revenue	0.08	0.02	-75.10
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.91	1.91	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.84	9.49	-31.46
Naive Interpretation	Member

06 - Financial Health · Weak

Rating